These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25582428)

  • 21. Real-world performance of an enhanced atrial fibrillation detection algorithm in an insertable cardiac monitor.
    Mittal S; Rogers J; Sarkar S; Koehler J; Warman EN; Tomson TT; Passman RS
    Heart Rhythm; 2016 Aug; 13(8):1624-30. PubMed ID: 27165694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptogenic stroke and atrial fibrillation in a real-world population: the role of insertable cardiac monitors.
    De Angelis MV; Di Stefano V; Franciotti R; Furia N; Di Girolamo E; Onofrj M; Faustino M
    Sci Rep; 2020 Feb; 10(1):3230. PubMed ID: 32094376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation.
    Sawhney N; Anousheh R; Chen W; Feld GK
    Circ Arrhythm Electrophysiol; 2010 Jun; 3(3):243-8. PubMed ID: 20339034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation.
    Pezawas T; Ristl R; Schukro C; Schmidinger H
    Clin Res Cardiol; 2016 Jan; 105(1):1-9. PubMed ID: 26105951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined dominant frequency and complex fractionated atrial electrogram ablation after circumferential pulmonary vein isolation of atrial fibrillation.
    Kumagai K; Sakamoto T; Nakamura K; Nishiuchi S; Hayano M; Hayashi T; Sasaki T; Aonuma K; Oshima S
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):975-83. PubMed ID: 23691953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of atrial fibrillation burden after surgical ablation: relevancy of end-point criteria after radiofrequency ablation treatment of patients with lone atrial fibrillation.
    Beukema R; Beukema WP; Sie HT; Misier AR; Delnoy PP; Elvan A
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):956-9. PubMed ID: 19762419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive surgery using bipolar radiofrequency energy is effective treatment for refractory atrial fibrillation.
    Kasirajan V; Spradlin EA; Mormando TE; Medina AE; Ovadia P; Schwartzman DS; Gaines TE; Mumtaz MA; Downing SW; Ellenbogen KA
    Ann Thorac Surg; 2012 May; 93(5):1456-61. PubMed ID: 22541178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring.
    Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Turov A; Shirokova N; Karaskov A
    J Cardiovasc Electrophysiol; 2011 Apr; 22(4):369-75. PubMed ID: 20958836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phased multipolar radiofrequency pulmonary vein isolation is as effective and safe as conventional irrigated point-to-point ablation. A prospective randomised 1-year implantable cardiac monitoring device follow-up trial.
    Podd SJ; Sulke AN; Sugihara C; Furniss SS
    J Interv Card Electrophysiol; 2015 Dec; 44(3):257-64. PubMed ID: 26310300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison.
    Willems S; Klemm H; Rostock T; Brandstrup B; Ventura R; Steven D; Risius T; Lutomsky B; Meinertz T
    Eur Heart J; 2006 Dec; 27(23):2871-8. PubMed ID: 16782716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: Results from the Reveal LINQ Usability Study.
    Sanders P; Pürerfellner H; Pokushalov E; Sarkar S; Di Bacco M; Maus B; Dekker LR;
    Heart Rhythm; 2016 Jul; 13(7):1425-30. PubMed ID: 26961298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.
    Theis C; Konrad T; Mollnau H; Sonnenschein S; Kämpfner D; Potstawa M; Ocete BQ; Bock K; Himmrich E; Münzel T; Rostock T
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1080-7. PubMed ID: 26297786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation--results of 5 years of follow-up.
    Hu QM; Li Y; Xu CL; Han J; Zhang HB; Han W; Meng X
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2174-80. PubMed ID: 24698564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term success and follow-up after atrial fibrillation ablation.
    Kircher S; Hindricks G; Sommer P
    Curr Cardiol Rev; 2012 Nov; 8(4):354-61. PubMed ID: 22920479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial.
    Kuck KH; Hoffmann BA; Ernst S; Wegscheider K; Treszl A; Metzner A; Eckardt L; Lewalter T; Breithardt G; Willems S;
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003337. PubMed ID: 26763226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.
    Verma A; Champagne J; Sapp J; Essebag V; Novak P; Skanes A; Morillo CA; Khaykin Y; Birnie D
    JAMA Intern Med; 2013 Jan; 173(2):149-56. PubMed ID: 23266597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.
    Brachmann J; Morillo CA; Sanna T; Di Lazzaro V; Diener HC; Bernstein RA; Rymer M; Ziegler PD; Liu S; Passman RS
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003333. PubMed ID: 26763225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.